COVID-19

Welcome to the COVID-19 era: the world is facing a pandemic that affects us all in one way or another. In close collaboration with partners, Swiss TPH is working hard to ensure that our core activities continue, in particular to support health systems that have been brought to their limits.

COVID-19 Activities at Swiss TPH

We are also actively engaged in the public health response to the COVID-19 pandemic, locally, nationally and internationally. Activities range from development of point-of-care diagnostics, designing and implementing seroprevalence studies and clinical trials with repurposed drugs, to mathematical modelling and computer-assisted algorithms to identify and reduce transmission.

Swiss TPH experts are contributing to the Swiss National COVID-19 Science Task Force, a national scientific advisory board set up specifically for the COVID-19 pandemic, and support Corona-Immunitas, a programme powered by the Swiss School of Public Health (SSPH+), which tests the proportion of people with antibodies to the corona virus in Switzerland.

From July to December 2020 Swiss TPH carries out the COVCO-Basel study, a long-term study on the effects of the coronavirus pandemic in the cantons of Basel-Stadt and Basel-Landschaft. The study contains both a digital survey that looks at the effects of COVID-19 on individual’s quality of life, as well as antibody testing (a seroprevalence study).

In collaboration with the canton of Basel-Landschaft and ETH Zurich, a validation study on COVID-19 antibody tests was carried out at the Diagnostic Centre of Swiss TPH in the second quarter of 2020.

On an international level, Swiss TPH joined the COVID-19 Clinical Research Coalition as one of 70 institutions to respond to COVID-19 in resource-poor setting.

The Botnar Research Centre for Child Health awarded 3 grants to Swiss TPH to combat COVID-19. The MODCOVID project seeks to harness mathematical modelling and machine learning approaches to guide and optimize clinical and public health strategies for the diagnosis, therapeutic interventions, disease surveillance and management in the emergency response to the COVID-19 pandemic. In the MistraL project carried out in Lesotho, artificial intelligence, chest X-ray and antigen-based diagnostic tests will be combined to enable and improve diagnosis of COVID-19 patients in low-income settings. This project will be carried out in collaboration with the Foundation for Innovative Diagnostics (FIND). The aim of the DaVinci project is to develop a simple, low-cost device that can detect antibodies against SARS-CoV-2, using saliva. The project seeks to identify individuals who have been previously infected with SARS-CoV-2 and to provide novel insights into the variations in the immune response to COVID-19.

In the EU-funded CORESMA project, Swiss TPH is leading the work package on implementation research to analyse effects of surveillance and containment measures through SORMAS in countries particularly vulnerable to the COVID-19 epidemic and to tailor effective and efficient control measures to health systems realities in Nepal and Côte d'Ivoire. Combining e-health, serolomics, modelling, artificial intelligence and implementation research, CORESMA aims to close existing gaps between clinical, epidemiological and immunological information in order to better respond to the pandemic. 

In many of our existing projects, we have increased the focus on activities to prevent and control COVID-19 infections.

Many thanks to all of our partners for your terrific collaboration, creativity, entrepreneurial spirit and solidarity. Together, we will come out of this crisis stronger and better prepared to make strides towards improving population health globally.

02.07.2020

Study Launched on Antibody Prevalence and Impact of Coronavirus in Basel

A long-term study on the effects of the coronavirus pandemic is being carried out in the cantons of Basel-Stadt and Basel-Landschaft. The study contains both a digital survey that... More...

27.05.2020

Swiss TPH Supports COVID-19 Efforts through Swiss Government Funding

The Swiss Agency for Development and Cooperation (SDC) is supporting the re-allocation of funds within existing projects that are implemented by Swiss TPH in Africa, Central Asia... More...

06.05.2020

"It Is a Race Against Time." An Interview with Claudia Daubenberger on Establishing a Diagnostic Lab for Sars-CoV-2 in Equatorial Guinea

COVID-19 poses major challenges for resource-limited countries, also when it comes to diagnostics. Swiss TPH is supporting Equatorial Guinea in establishing one of the few... More...

Swiss TPH employees and students who can perform their work remotely have been working in home offices for the past few weeks and are fully reachable, preferably by email (find your contact person here).

We have adapted our course offering and medical services to ensure the utmost protection of our employees, students and clients.

The public vaccination consultation hours will remain closed in order to be able to comply with the distance rules.

Appointments for vaccinations and consultations before travelling are possible again with immediate effect and can be arranged by calling the following telephone number:

061 284 82 55 Monday - Friday 08:00 - 12:00

Medical consultations can also be arranged by calling the above telephone number.

In case of medical emergencies, please contact our emergency number: 061 284 81 44

Thank you very much for your understanding.

We continuously adapt our teaching activities to the current situation and requirements; approaches are in accordance with those promoted by the University of Basel.

Regarding our professional postgraduate courses please visit the individual course pages for more information.

For questions, please contact coursesswisstph.ch.

Until further notice the Swiss TPH library is closed. Please contact us per mail for any question: libraryswisstph.ch.

Information on the current situation, federal government measures, recommendations for workplace and for travellers, and answers to frequently asked questions can be found on the website of the Federal Office of Public Health FOPH.